Perelman School of Medicine at the University of Pennsylvania

Robertson Lab

Publications: 1990-2000

pub bar

 1990 ♦ 19921993 ♦ 1994 ♦ 1995 ♦ 1996 1997 ♦ 1998 ♦ 1999 ♦ 2000 
  Journal of Virology, Vol 175, Apr 1990 ♦  Protein kinase of bacteriophage T7 induces the phosphorylation of only a small number of proteins in the infected cell. Erle S. Robertson, Allen W. Nicholson.
  BioChemistry, Vol 31, 1992 ♦  Phosphorylation of Escherichia coli translation initiation factors by the bacteriophage T7 protein kinase. Erle S. Robertson and Allen W. Nicholson.
1 Journal of Virology, Dec 1993 ♦ Epstein-Barr virus recombinants from overlapping cosmid fragments. B Tomkinson, E Robertson, R Yalamanchili, R Longnecker, and E Kieff.  
2 Journal of Virology, Apr 1993 ♦  Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. B Tomkinson, E Robertson, and E Kieff.
1 Journal of Virology, Mar 1994 ♦  An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. E S Robertson, B Tomkinson, and E Kieff.
2 Molecular Microbiology, 1994 11(6) ♦  Phosphorylation of elongation factor G and ribosomal protein S6 in bacteriophage T7-infected Escherichia coli. Erle S. Robertson, Lee A. Aggison and Allen W. Nicholson
3 Book Epstein-Barr Virus Recombinants 1994 ♦ Specifically Mutated Epstein-Barr Virus Recombinants: Defining The Minimal Genome For Primary B Lymphocyte Transformation. E. Kieff, K. Izumi, K. Kaye, R. Longnecker, J. Mannick, C. Miller, E. Robertson, S. Swaminathan, B. Tomkinson, X. Tung, and R. Yalamanchili.   
1995                                                                                                                             Back to Top
1 Journal of Virology, Feb 1995 ♦  Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. E Robertson, and E Kieff.
2 Journal of Virology, May 1995 ♦  Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. E S Robertson, S Grossman, E Johannsen, C Miller, J Lin, B Tomkinson, and E Kieff.
1996                                                                                                                            Back to Top
  Journal of Virology, May 1996 ♦  The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). E S Robertson, J Lin, and E Kieff.
1997                                                                                                                            Back to Top
1 Genetic Engineering of Viruses and of Virus Vectors, Oct 1997 ♦  Epstein-Barr virus vectors for gene delivery to B lymphocytes. Erle S. Robertson, Tadamasa Ooka, And Elliott D. Kieff.
2 Journal of Biological Chemistry, Vol 272 Arp 25, 1997 ♦  Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate with RBP-Jκ and Activate Transcription. Jon C. Aster, Erle S. Robertson, Robert P. Hasserjian, Jerrold R. Turner, Elliott Kieff, and Jeffrey Sklar.
1998                                                                                                                            Back to Top
  Immunity, Vol 9, Issue 4, Oct 1998  ♦  Prevention of Acute Allograft Rejection by Antibody Targeting of TIRC7, a Novel T Cell Membrane Protein. Nalân Utku, Thomas Heinemann, Stefan G Tullius, Grit-Carsta Bulwin, Sören Beinke, Richard S Blumberg, Francisca Beato, Jeffrey Randall, Ryoji Kojima, Liliana Busconi, Erle S Robertson, Ralf Schülein, Hans-Dieter Volk, Edgar L Milford, Steven R Gullans. 
1999                                                                                                                            Back to Top
1 Feb 1999 ♦ Technology evaluation: DISC. Erle S. Robertson.
2 Journal of Virology, Vol 262, Sep 1999 ♦  Distinct Patterns of Viral Antigen Expression in Epstein–Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Coinfected Body-Cavity-Based Lymphoma Cell Lines: Potential Switches in Latent Gene Expression Due to Coinfection. Jennifer Callahan, Seema Pai, Murray Cotter, Erle S. Robertson.
3 Journal of Virology, Vol 346, Nov 1999 ♦ The Latency-Associated Nuclear Antigen Tethers the Kaposi's Sarcoma-Associated Herpesvirus Genome to Host Chromosomes in Body Cavity-Based Lymphoma Cells. Murray A. Cotter, Erle S. Robertson.
4 Journal of Virology, Vol 264, Nov 1999 ♦  Characterization of Intertypic Recombinants of the Epstein–Barr Virus from the Body-Cavity-Based Lymphomas Cell Lines BC-1 and BC-2. Andrew J. Aguirre, Erle S. Robertson.
2000                                                                                                                            Back to Top
1 Journal of Virology, Jan 2000 ♦  Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus. Andrew J. Aguirre and Erle S. Robertson.
2 Journal of Virology, Feb 2000 ♦ Intracellular Forms of Human NOTCH1Functionally Activate Essential Epstein-Barr Virus Major Latent Promoters in the Burkitt's Lymphoma BJAB Cell Line but Repress These Promoters in Jurkat Cells. Murray Cotter, Jennifer Callahan, Jon Aster, and Erle Robertson.
3 Molecular and Cellular Biology, Aug 2000 ♦ Modulation of Histone Acetyltransferase Activity through Interaction of Epstein-Barr Nuclear Antigen 3C with Prothymosin Alpha. Murray A. Cotter, II, Erle S. Robertson.
4 BioThechniques, Mar 2000 ♦ Improved Transfection Efficiency of 293 Cells by Radio Frequency Electroporation. Philip B. Zald, Murray A. Cotter II, and Erle S. Robertson.